INS and Insulin resistance: The results indicated that fenofibrate treatment reduced homeostasis model assessment-insulin resistance (HOMA-IR) values (Figure 3A; Supplementary Table S2) and increased homeostasis model assessment-insulin sensitivity index (HOMA-ISI) (Figure 3B; Supplementary Table S2).